Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

BUY
$0.07 - $0.12 $139,753 - $239,576
1,996,473 Added 1050.78%
2,186,473 $160,000
Q2 2021

Aug 06, 2021

SELL
$0.07 - $0.12 $139,753 - $239,576
-1,996,473 Reduced 91.31%
190,000 $160,000
Q3 2017

Nov 06, 2017

BUY
$0.06 - $0.07 $131,188 - $153,053
2,186,473
2,186,473 $153,000

About MYMETICS CORP


  • Ticker MYMX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 303,758,016
  • Description
  • Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporatio...
More about MYMX
Track This Portfolio

Track Iat Reinsurance CO Ltd. Portfolio

Follow Iat Reinsurance CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iat Reinsurance CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Iat Reinsurance CO Ltd. with notifications on news.